Search clinical trials for: Gemcitabine - 28 day cycle
Total 376 results
-
Korea University Guro HospitalEnrolling by invitationLumbar Spine DiseaseKorea, Republic of
-
ShireCompletedHereditary Angioedema (HAE)United States, Germany, Spain, Sweden
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingRecurrent/Refractory Acute Myeloid Leukemia, Myelodysplastic SyndromesChina
-
Sidney Kimmel Comprehensive Cancer Center at Johns...TerminatedNon-small Cell Lung Cancer MetastaticUnited States
-
Jazz PharmaceuticalsCompletedMultiple SclerosisUnited Kingdom
-
Tiziana Life Sciences LTDNot yet recruiting
-
TO PharmaceuticalsCompletedAgitation Related to DementiaIsrael
-
Jazz PharmaceuticalsCompleted
-
Washington University School of MedicineCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteUnited States
-
AryoGen Pharmed Co.CompletedMalignant Neoplasm of BreastIran, Islamic Republic of
-
Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.Shenzhen Second People's HospitalUnknown
-
Daegu Catholic University Medical CenterCompletedAnesthesia Intubation ComplicationKorea, Republic of
-
M.D. Anderson Cancer CenterGenentech, Inc.Active, not recruitingNon-Small Cell Lung Cancer | Lung CancerUnited States
-
Astellas Pharma Global Development, Inc.Merck Sharp & Dohme LLC; Seagen Inc.RecruitingUrothelial CancerUnited States, Argentina, Australia, Belgium, Canada, China, Czechia, Denmark, France, Germany, Hungary, Israel, Italy, Japan, Korea, Republic of, Netherlands, Poland, Russian Federation, Singapore, Spain, Switzerland, Taiwan, Thailand and more
-
Jazz PharmaceuticalsCompleted
-
Eisai Inc.CompletedAcute Myeloid LeukemiaUnited States, Poland, Australia, Spain, France, Canada, Mexico, Romania, Taiwan, Russian Federation, Hungary, Serbia, Croatia, United Kingdom, Czechia
-
Far Eastern Memorial HospitalUnknown
-
AstraZenecaRecruitingHyperkalaemiaChina, Germany, United States, Ukraine, Spain, Japan, United Kingdom, Canada, Poland, Romania, Russian Federation, Brazil
-
Baylor College of MedicineChildren's Hospital of Philadelphia; Dana-Farber Cancer Institute; University... and other collaboratorsCompletedBrain TumorsUnited States
-
Gruppo Oncologico Italiano di Ricerca ClinicaUnknown
-
University of Roma La SapienzaCompleted
-
National Cancer Institute (NCI)WithdrawnMelanoma | Sarcoma | Neoplasms, Germ Cell and Embryonal | Neoplasm Metastasis
-
National Cancer Institute (NCI)CompletedSorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable MelanomaMelanoma | Recurrent Melanoma | Stage IV Melanoma | Stage III MelanomaUnited States
-
Shanghai University of Traditional Chinese MedicineFudan University; Shanghai Chest HospitalCompleted
-
Seoul National University HospitalCompletedAnesthesia; FunctionalKorea, Republic of
-
Edda SpiekerkoetterStanford UniversityCompletedPulmonary Arterial HypertensionUnited States
-
Yonsei UniversityCompletedColorectal CancerKorea, Republic of
-
Radboud University Medical CenterUMC Utrecht; Prothya BiosolutionsCompletedSepsis | Inflammation | Endotoxemia | Innate Immune ResponseNetherlands
-
Fujian Cancer HospitalNot yet recruiting
-
Ferrer Internacional S.A.TerminatedCerebral Infarction | Acute StrokeSpain, Germany, Portugal
-
Shanghai Jiao Tong University School of MedicineCompleted
-
National Cancer Institute (NCI)CompletedRecurrent Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v7 | Stage IV Renal Cell Cancer AJCC v7United States
-
National Cancer Institute (NCI)TerminatedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) | Secondary Acute Myeloid Leukemia and other conditionsCanada
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Recurrent Melanoma | Recurrent Bladder Cancer | Stage IV Bladder Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IV Melanoma | Recurrent Breast Cancer | Stage III MelanomaUnited States
-
Duramed ResearchCompletedBone Mineral DensityUnited States
-
National Cancer Institute (NCI)TerminatedSecondary Acute Myeloid Leukemia | Childhood Acute Myeloblastic Leukemia With Maturation (M2) | Childhood Acute Promyelocytic Leukemia (M3) | Recurrent Childhood Acute Lymphoblastic Leukemia | Recurrent Childhood Acute Myeloid LeukemiaUnited States
-
CelgeneCompleted
-
Fate TherapeuticsRecruitingRelapsed/Refractory B-Cell LymphomaUnited States
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)CompletedUnspecified Adult Solid TumorUnited States
-
National Cancer Institute (NCI)TerminatedUnspecified Adult Solid Tumor, Protocol Specific | Hematopoietic/Lymphoid CancerUnited States
-
ImmunityBio, Inc.CompletedMetastatic, Locally Advanced or Unresectable Soft Tissue SarcomaUnited States, Spain, Denmark, Israel, Canada, Australia, Hungary, Chile, France, Italy, Netherlands, Poland, Russian Federation
-
Eli Lilly and CompanyCompletedBack Pain | Osteoporosis, Postmenopausal | Spinal FractureItaly, Mexico, Australia, United States, Germany, Belgium, Puerto Rico, Sweden, Brazil, France, Canada, Spain, Argentina
-
Fudan UniversityActive, not recruitingTA(E)C-GP Versus A(E)C-T for the High Risk TNBC Patients and Validation of the mRNA-lncRNA SignatureBreast Cancer | Triple Negative Breast CancerChina
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)TerminatedLung CancerUnited States, Australia
-
Istituto Clinico HumanitasCompleted
-
Charite University, Berlin, GermanyUnknown
-
Teva Branded Pharmaceutical Products R&D, Inc.Completed
-
National Cancer Institute (NCI)TerminatedCarcinoma, Non-Small-Cell Lung | Non-Small Cell Lung Cancer | Lung Cancer | Carcinoma, Esophageal | Malignant Pleural MesotheliomasUnited States
-
Menzies School of Health ResearchNational Institute of Health Research and Development, Ministry of Health... and other collaboratorsCompletedSmear Positive Pulmonary TuberculosisIndonesia
-
National Cancer Institute (NCI)M.D. Anderson Cancer CenterWithdrawnSorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable MelanomaMelanoma | Recurrent Melanoma | Stage IV Melanoma | Stage III Melanoma